Effectiveness of Booster Dose of Anti SARS-CoV-2 BNT162b2 in Cirrhosis: Longitudinal Evaluation of Humoral and Cellular ResponseVincenzo Giambra, Alessandra Mangia, Chiara Cavorsi et al.|Vaccines|2022Cited by 20
Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine DoseAlessandra Mangia, Valeria Piazzolla, Nicola Serra et al.|Frontiers in Public Health|2022Cited by 16
Early Serological Response to BNT162b2 mRNA Vaccine in Healthcare WorkersGiovanna Cocomazzi, Alessandra Mangia, Nicola Serra et al.|Vaccines|2021Cited by 15